Cytotoxicity of nanoscaled metal–organic frameworks by Tamames-Tabar, C. (Cristina) et al.
Journal of
Materials Chemistry B
PAPER
Pu
bl
ish
ed
 o
n 
30
 O
ct
ob
er
 2
01
3.
 D
ow
nl
oa
de
d 
by
 U
ni
ve
rs
id
ad
 d
e 
N
av
ar
ra
 o
n 
28
/1
0/
20
14
 1
0:
53
:1
5.
 
View Article Online
View Journal  | View IssueaInstitut Lavoisier, UMR CNRS
Saint-Quentin-en-Yvelines, 45 Avenue de
France. E-mail: horcajada@chimie.uvsq.fr;
39254371
bDepartamento de Farmacia y Tecnolog´ıa
Universidad de Navarra, Irunlarrea 1, 3100
unav.es; Fax: +34 948425649; Tel: +34 9484
† Electronic supplementary informatio
non-commercialised linkers, the MOF syn
See DOI: 10.1039/c3tb20832j
‡ These authors contributed equally to th
§ These authors are equal senior authors.
Cite this: J. Mater. Chem. B, 2014, 2,
262
Received 10th June 2013
Accepted 25th October 2013
DOI: 10.1039/c3tb20832j
www.rsc.org/MaterialsB
262 | J. Mater. Chem. B, 2014, 2, 262–Cytotoxicity of nanoscaled metal–organic
frameworks†
Cristina Tamames-Tabar,‡ab Denise Cunha,‡a Edurne Imbuluzqueta,‡b
Florence Ragon,a Christian Serre,a Mar´ıa J. Blanco-Prieto§*b and Patricia Horcajada§*a
A series of fourteen porous Metal–Organic Frameworks (MOFs) with diﬀerent compositions (Fe, Zn, and Zr;
carboxylates or imidazolates) and structures have been successfully synthesised at the nanoscale and fully
characterised by XRPD, FTIR, TGA, N2 porosimetry, TEM, DLS and z-potential. Their toxicological
assessment was performed using two diﬀerent cell lines: human epithelial cells from foetal cervical
carcinoma (HeLa) and murine macrophage cell line (J774). It appears that MOF nanoparticles (NPs)
exhibit low cytotoxicity, comparable to those of other commercialised nanoparticulate systems, the less
toxic being the Fe carboxylate and the more toxic being the zinc imidazolate NPs. The cytotoxicity
values, higher in J774 cells than in HeLa cells, are mainly function of their composition and cell
internalisation capacity. Finally, cell uptake of one of the most relevant Fe-MOF-NPs for drug
vectorisation has been investigated by confocal microscopy studies, and indicates a faster kinetics of cell
penetration within J774 compared to HeLa cells.Introduction
Metal–Organic Frameworks or MOFs are still considered as
being a hot research topic in material chemistry1 as illustrated
through their highly porous hybrid character built from inor-
ganic units and organic polycomplexing linkers. Their easily
tuneable structure, composition and porosity allow careful
switching of their physico-chemical properties. This huge
chemical and structural versatility makes them promising
candidates for main relevant applications such as gas storage,
separation, heat transformation, catalysis and sensing, among
others.1,2 Recently, their use in biomedicine has been
proposed,3 including contrast agents for imaging techniques4
and the encapsulation for controlled delivery of molecules,
such as drugs,5 cosmetics6 and biologically active gases (NO,
H2S, etc.).7
The control of MOF particle size in the nanometric range8
has paved the way for their use in nanotechnology.9 It is8180, Universite´ de Versailles
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271noteworthy that nanoscale non-toxic porous iron(III)-based
MOFs with engineered cores and surfaces have been proposed
as nanocarriers for the controlled delivery of antitumoral and
anti-HIV drugs, with additional imaging properties.9b,10 Also,
they enable the progressive release of the drug into the cells.9b
However, prior to any bioapplication of MOF nanoparticles
(NPs), their toxicity has to be established.11 Until now, the
available toxicity information remains very scarce, mostly
related either to the inorganic and organic precursors or in vitro
cytotoxicity studies.12 For instance, Liu and co-workers have
reported values of the half maximal inhibitory concentration
(IC50) of 46 mg mL
1 for the silica-coated MIL-101_NH2-Br-
BODIPY NPs on human colon adenocarcinoma cells (HT-29).13
However, both the uorophore moiety and the silica coating of
these NPs might also inuence their cytotoxicity.10 Additionally,
the in vitro toxicity of lanthanide-based MOFs14 was carried out
in human colon adenocarninoma (HT-29) and in acute
lymphoblastic leukaemia human cells, showing important
cytotoxicity values (IC50  10 and 15 mg mL1, respectively) due
a priori to the linkers’ antitumoral own activity.
Finally, the only reported in vivo studies so far concern the
intravenous injection of high doses (up to 220 mg kg1) of three
porous iron(III) carboxylate NPs based on diﬀerent organic
linkers. All the studied parameters (serum, enzymatic, histo-
logical, etc.) evidenced a lack of severe acute and subacute
(150 mg kg1 for four consecutive days) toxicity. NPs were
rapidly captured by the liver and spleen and then, degraded into
their constitutive components (iron and carboxylate ligand),
allowing the direct removal in around 15 days of iron and
exogenous linkers by the urine and faeces without anyThis journal is © The Royal Society of Chemistry 2014
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View Article Onlinemetabolisation.9b,15 Note that biodistribution and elimination
kinetics might depend on the MOF nature. Thus, despite these
encouraging results, further studies must be performed on
diﬀerent MOF structures paying special attention to their long-
term toxicity.
Therefore, we propose here the investigation of the cytotox-
icity of a series of benchmarked MOF NPs, using two diﬀerent
cell lines, in order to evaluate the inuence of their topology,
composition, biological stability, particle size and surface
charge with regard to their cell toxicity. The chosen MOF NPs
are: (i) the cubic-zeotype mesoporous MIL-100 and MIL-101
solids (MIL: Material of Institut Lavoisier) built from trimers of
iron(III) octahedra and tricarboxylic acids (trimesate, BTC) for
MIL-100 or 2-amino or 2,5-dimethyl terephthalates (BDC_NH2
or BDC_2CH3) for MIL-101_NH2 and _2CH3, respectively, which
all exhibit a very high porous character;9b,16 (ii) the cubic struc-
ture Soc-MOF (Fe) or MIL-127, based on iron(III) octahedra
trimers and 3,30,5,50-azobenzenetetracarboxylate anions
(Tabz);17 (iii) the cubic structure UiO-66 (UiO: Oslo University)
based on zirconium(IV) oxo-clusters and terephthalate anions
(BDC);18 (iv) the exible series of isoreticular MIL-88,19 built
from iron(III) oxo-centered trimers connected by dicarboxylates
bridges (fumarate for MIL-88A; terephthalate for MIL-88B). In
addition, the physico-chemical properties and porosity of these
solids are tuned through the graing of diﬀerent organic
functional groups on the aromatic ring of the terephthalate
linker, such as NH2, NO2, CH3, 2CH3 and 4CH3
(for MIL-88B_NH2, _NO2, _CH3, _2CH3 and _4CH3, respec-
tively)20 and nally (v) the cubic architecture ZIF-8 (ZIF-8:
Zeolitic Imidazolate Framework) based on a microporous zinc
2-methyl-imidazolate.21
The present work aims to: (i) evaluate the cytotoxicity of
MOFs in the human cervical cancer cell line (HeLa) and in the
mouse macrophage cell line (J774) by the MTT assay22 and (ii)
study the cellular uptake of MIL-100(Fe) using the same cells,
taking into account its exceptional drug loadings and controlled
releases.6,9b,23 HeLa cells were chosen due to possible dermal
applications of MOFs containing cosmetic agents6,24 and J774
for being a cell line of choice for cellular uptake studies.Experimental section
Material synthesis
NPs of MIL-100(Fe),9b MIL-101_NH2,9b MIL-101_2CH3,25
MIL-88A,19b MIL-88B_4CH3,9b ZIF-8,21 MIL-88B_CH3,20 MIL-
88B_2CH320 and MIL-88B_2CF320 were prepared as previously
reported. Nanometric MIL-127, UiO-66, MIL-88B, MIL-88B_NH2
and MIL-88B_NO2 were synthesised by diﬀerent methods
(round bottom ask or microwave assisted hydro/solvothermal
route; see ESI†). Microwave-assisted syntheses were done using
a MARS-CEM® microwave (USA).
For uorophore ((R)-()-4-(3-aminopyrrolidino)-7-nitro-
benzofurazan, furazan) encapsulation, 1 mg of the dehydrated
MIL-100(Fe) microparticles (MPs) or NPs (100 C overnight) was
suspended into 200 mL of a 32 mg mL1 furazan aqueous solu-
tion under rotational stirring for 2 h at room temperature (RT).This journal is © The Royal Society of Chemistry 2014The particles were later recovered by centrifugation (15 000g/15
min) and washed with deionised water.
Material characterisation
X-ray powder diﬀraction (XRPD) patterns were collected using a
SIEMENS D5000 diﬀractometer (Siemens, Germany) (q–2q)
using Cu Ka1,2 radiation (l 1.54056 A˚) from 5 to 15 (2q) using
a step size of 0.04 and 4 s per step in continuous mode. Fourier-
transform infrared (FTIR) spectra were obtained with a Thermo
Nicolet spectrometer (Thermo, USA) and were recorded from
4000–400 cm1 at RT. Approximately 5–10 mg of each sample
were used for thermogravimetric analysis (TGA) measurements
and were analysed under an O2 ow (20 mL min
1) with a
Perkin Elmer Diamond TGA/DTA STA 6000 running from 20 to
600 C at a scan rate of 2 C min1. Nitrogen porosimetry of the
rigid materials was carried out with a Belsorp mini II® poros-
imeter (BEL Japan Inc.). Morphological analysis was done with a
Transmission Electron Microscopy (TEM) Darwin 208 Philips
60-80-100 kV coupled to an AMT camera. The particle size and
polydispersity index (PDI) were measured in phosphate buﬀer
solution (PBS) 0.271 mM pH 7.2 by dynamic light scattering
(DLS) and surface charge (z-potential) by laser Doppler
electrophoresis using a Zetasizer Nano-ZS® analyser system
(Malvern Instruments, UK).
For the experimentally estimated log P, 1 mg of each linker
was added to 1 mL of water and 1 mL of n-octanol and main-
tained at 37 C under rotational stirring overnight. Then, both
fractions were separated by centrifugation (8000g/15 min) and
the amount of each linker in each fraction was measured
using an Agilent 8453 Ultraviolet Spectrophotometer (Agilent
Technologies, USA).
Finally, for furazan delivery studies, 5 mg of furazan-graed
MIL-100(Fe) NPs were suspended in 1 mL of RPMI cell culture
medium under stirring at 37 C to simulate in vitro conditions.
Aliquots of 20 mL were collected every 30 min and the amount of
delivered furazan was quantied by uorescence spectroscopy
using a Cary® UV-VIS-NIR Spectrophotometer (Varian, USA) at
lem and lex of 535 and 500 nm, respectively.
Cell culture and cytotoxicity assays
The J774 cell line (ATCC TIB-67) was maintained in RPMI 1640
medium supplemented with glutamax®, 10% of heat-inacti-
vated foetal bovine serum and 1% of antibiotic antimycotic
solution. HeLa cells (ATCC CCL-2) were cultured in DMEM
medium supplemented with 1% of L-glutamine, 10% of heat-
inactivated foetal bovine serum and 1% of antibiotic anti-
mycotic solution. Both cell lines were grown at 37 C in a
humidied 5% CO2 atmosphere and passaged twice a week
(at 80% of conuence) at a density of 5  104 cells per cm2.
The cytotoxic activity of the NPs and their constitutive linkers
was analysed by the MTT assay,22 the amount of linker being
tested with the molar equivalent of its amount in the NP. 24 h
prior to the assay, the cells were seeded in 96-well plates at a
density of 1  104 cells per well. The treatments (MOF NPs and
linkers) were prepared at a 10-fold higher concentration (due to
a direct 1/10 direct dilution in the well, as 20 mL of treatmentsJ. Mater. Chem. B, 2014, 2, 262–271 | 263
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View Article Onlinewere added to a nal volume of 200 mL per well). They were
solubilised (in the case of the linkers) or dispersed (in the case
of the MOF NPs) in cell culture medium containing 0.5%
DMSO. Then they were added to the cells at diﬀerent concen-
trations (until a nal concentration of 2.5 mg mL1) and kept
24 h at 37 C with a 5% CO2 atmosphere. The cytotoxicity was
determined aer 24 h by adding the MTT reactant (0.5 mgmL1
in PBS, incubation at 37 C during 2 h) followed by 200 mL of
DMSO to each well. The plates were read at l ¼ 540 nm.
Finally, it was determined that a DMSO concentration of
0.5%, corresponding to the maximum amount added to
homogenise the treatments, was not toxic.26 Also, the cell
culture medium pH was measured before and aer each MTT
assay, the pH variations being minimal (see ESI†).Cellular penetration assays: confocal microscopy
For MIL-100(Fe) NPs uptake studies, J774 and HeLa cells were
seeded at a density of 1  105 cells per well on glass coverslips
placed in 24-well plates. Aer 24 h, cells were washed with PBS
and incubated with 0.25 mg of furazan-engraed MIL-100(Fe)
NPs in complete cell culture medium. Untreated cells and cells
treated with 10 mg mL1 of free furazan were included as
controls. Aer appropriate incubation times, cells were exten-
sively washed with PBS to remove the excess of non-internalised
material, xed in 4% p-formaldehyde for 5 min and incubated
with the nuclear dye TOPRO-3 (1 : 1000 in PBS, 5 min). Finally,
coverslips were mounted with Dako Fluorescent mounting
medium onto glass slides and cells were examined using a Zeiss
LSM 510 META confocal microscope with a Plan-Apochromat
AN objective (Carl Zeiss Microscope Systems, Zena, Germany)
equipped with an Ar laser at 488 nm together with a lter at
505 nm. The images were analysed using the LSM Image
Browser Carl Zeiss Advanced Imaging Microscopy Release
4.2 soware.Results and discussion
Synthesis and characterisation of MOFs
Fourteen types of MOF NPs (Table 1) with diﬀerent structures
and compositions have been successfully synthesised, as rst
conrmed by XRPD, which shows the characteristic Bragg peaks
of the bulk MOFs with broadness, in agreement with the
smaller crystal size (Fig. S1†).
It is noteworthy that some synthesis routes were slightly
modied in order to obtain high yields (>70%) of small and well
monodispersed NPs (Table 1). This is the case for the
MIL-88B_NH2 and MIL-88B_NO2 solids, previously obtained as
MPs by the solvothermal route.20 However, this required the use
of toxic solvents such as N,N0-dimethylformamide or methanol
(i.e. MIL-127, MIL-101_2CH3, UiO-66, MIL-88B, MIL-88B_CH3,
_2CH3 and _4CH3). Thus, before studying the in vitro toxicity of
the NPs, purication and/or activation steps (see ESI†) were
carried out to avoid the presence of remaining traces of the toxic
solvent. TGA and FTIR spectra both conrmed the absence of
any impurities (residual organic linkers or solvents) in the nal
products (Table S1 and Fig. S2†). Moreover, except for the264 | J. Mater. Chem. B, 2014, 2, 262–271exible porous MIL-88 type solids, which showed no accessible
porosity in their dehydrated (closed) form, the permanent
porosity of rigid MOF NPs was evaluated by nitrogen adsorption
at 77 K, leading to results close to those of the bulk materials
(Table S2†).16–18,21
Concerning the resulting particle sizes, most NPs exhibited
mean diameters close to 100 nm associated with low poly-
dispersity indices (PDI < 0.2) (Table 1). In contrast, MIL-127
NPs presented a higher particle size (476  82 nm) with a high
PDI as a consequence of an important aggregation process in
solution. Similarly, ZIF-8 and UiO-66 NPs exhibited larger
dimensions in solution (DLS) than in their dry state (TEM)
(60 and 30 vs. 100 and 90 nm, respectively), due to an
aggregation eﬀect, as also evidenced by TEM (Fig. 1). Indeed,
TEM images showed rather small and monodispersed NPs
bearing diﬀerent morphologies. Well-faceted crystals with a
more or less elongated hexagonal morphology or octahedral-
cubic shape were observed for the MIL-88 solids or
MIL-100/101/127 NPs, respectively, whereas ZIF-8 and UiO-66
NPs disclosed a spherical morphology associated with an
important aggregation.
Along with particle sizes in the same range, all MOF NPs
exhibited negative surface charges in PBS, the most negative
being the hydrophobic solids MIL-88B_2CF3 and
MIL-88B_4CH3 (53.2 7.3 and41.3 0.6 mV). Interestingly,
analysis of the (CH3)n functionalised MIL-88B NPs suggests that
the increase in the number of methyl groups per spacer leads to
more negatively charged particles (22.8 2.2,26.0 0.4 and
41.3  0.6 mV for n¼ 2, 3 and 4, respectively). In addition, the
zeta potential has also been determined in DMEM cell culture
media + 10% fetal bovine serum (FBS; see Table S3†),
evidencing less negative surface charges. These less negative
values, in agreement with the zeta potential value obtained for
the medium without MOFs (8.32  0.25 mV), indicate the
adsorption of proteins present in themedium andmight permit
the interaction between and the NPs and the cell membrane.
With the aim to visualise the NPs inside the cells and further
study their interactions with cells, a uorophore was associated
with the MIL-100(Fe) NPs. Furazan was selected since: (i) it
possesses functional groups (amino, nitro and heterocyclic
heteroatoms), which are a priori able to strongly interact with
the coordinatively unsaturated metal sites (CUS) of MIL-100(Fe)
NPs, preventing the leaching during the in vitro tests; (ii) it bears
small dimensions (5.5  10.6  3.7 A˚) allowing furazan to be
trapped within the pores (windows size 8.6 and 4.7  5.7 A˚);
(iii) its high aqueous solubility (3.14 mg mL1) and (iv) its easy
and sensible detection and quantication.
First, furazan (Fig. 2A) was loaded into the MIL-100(Fe) MPs
crystals (1–5 mm) to allow its localization within the particles.
A simple impregnation of the MPs within a furazan aqueous
solution (see the Experimental section) was carried out to
ensure its homogeneous distribution within the pores, as
evidenced by confocal microscopy (Fig. 2C). Then, MIL-100(Fe)
NPs were similarly functionalised achieving a furazan graing
of around 11.4% wt, as conrmed by uorescence spectroscopy.
Although the microscopy resolution did not allow distinguish-
ing the location of the furazan within the NPs, it can beThis journal is © The Royal Society of Chemistry 2014
Table 1 Physico-chemical characterisation of MOF NPs (particle size and z-potential), and their IC50 values at 24 h in J774 and HeLa cells
MOF NPs Ma Lb Rn
c Size (nm) z-Pot (mV)
IC50 (mg mL
1)
HeLa J774
MOF NPs Lb MOF NPs Lb
MIL-127
Fe
Tazbd
— 476  82 38.5  2.0 >2.00 0.80  0.02 0.44  0.02 0.82  0.17
MIL-100
BTCe
— 120  40 18.3  0.6 1.10  0.15 2.00  0.06 0.70  0.02 >1.00
MIL-101_2CH3
BDC_Xf
(CH3)1,3(H)2,4 120  15 24.2  2.1 >2.50 >1.70 0.17  0.01 0.08  0.01
MIL-101_NH2 (NH2)1,(H)2–4 100  18 27.4  1.5 >1.00 0.60  0.01 0.07  0.002 0.02  0.004
MIL-88A
FUMg
— 105  15 25.0  4.3 0.015  0.005 0.03  0.003 0.05  0.002 0.40  0.01
MIL-88B
BDC_Xf
(H)1–4 100  20 23.5  1.8 1.26  0.08 0.80  0.02 0.37  0.08 0.43  0.03
MIL-88B_CH3 (CH3)1,(H)2–4 75  20 22.8  2.2 >2.00 1.05  0.03 0.37  0.01 0.24  0.02
MIL-88B_2CH3 (CH3)1,3(H)2,4 100  20 26.0  0.4 2.10  0.08 >1.70 0.36  0.03 0.08  0.01
MIL-88B_4CH3 (CH3)1–4 120  20 41.3  0.6 0.69  0.02 >2.00 0.08  0.01 0.42  0.01
MIL-88B_2CF3 (CF3)1,3(H)2,4 105  30 53.2  7.3 >2.00 1.12  0.08 0.41  0.01 0.57  0.01
MIL-88B_NH2 (NH2)1,(H)2–4 115  20 25.7  1.6 1.10  0.02 0.60  0.01 0.45  0.03 0.02  0.004
MIL-88B_NO2 (NO2)1,(H)2–4 130  15 28.4  0.7 >2.00 >2.00 0.03  0.001 0.17  0.01
UiO-66 Zr (H)1–4 100  20 26.3  1.5 0.40  0.01 0.80  0.02 0.06  0.001 0.43  0.03
ZIF-8 Zn
MIh
— 90  15 11.0  0.6 0.10  0.01 1.40  0.02 0.025  0.001 >1.00
a M: metal. b L: linker. c Rn: functionalisations.
d Tabz: azobenzenetetracarboxylic acid. e BTC: 1,3,5-benzenetricarboxylic acid. f BDC-X:
1,4-dicarboxylic acid or terephthalic acid. g FUM: fumaric acid. h MI: 2-methylimidazolate.
Paper Journal of Materials Chemistry B
Pu
bl
ish
ed
 o
n 
30
 O
ct
ob
er
 2
01
3.
 D
ow
nl
oa
de
d 
by
 U
ni
ve
rs
id
ad
 d
e 
N
av
ar
ra
 o
n 
28
/1
0/
20
14
 1
0:
53
:1
5.
 
View Article Onlineconsidered that the uorophore was homogeneously distrib-
uted within the pores, similar to the MPs.
Finally, the stability of the graing was evaluated by incu-
bating the furazan-loaded MIL-100(Fe) NPs in cell culture
media. The released furazan was quantied by uorescence
spectroscopy (Fig. 2B). Furazan showed a slow delivery from the
NPs, with less than 5 and 15% of the graed furazan (0.02 and
0.06 mg per 100 mg of dehydrated MIL-100(Fe) NPs) released
aer the rst 2 and 7 h, respectively. Consequently, the stability
of the loaded furazan within the NPs is high enough to follow
the cellular penetration of the furazan-graed MIL-100(Fe) NPs
within diﬀerent cell lines.This journal is © The Royal Society of Chemistry 2014Cytotoxicity evaluation
The high chemical and/or structural versatility (metal, organic
linker, and structure of the MOFs) introduces many factors that
shall impact the resulting cytotoxicity. Furthermore, cytotoxicity
was studied using HeLa and J774 cells (Table 1), nding a cell
type specic response to the treatments, which was attributed to
the diﬀerent phagocytic characteristics of the used lines, as will
be further considered.
Eﬀect of the topology. Interestingly, the cytotoxicity of poly-
morphs (identical composition but diﬀerent crystalline
structures) such as the iron amino-terephthalates MIL-88B_NH2J. Mater. Chem. B, 2014, 2, 262–271 | 265
Fig. 1 Transmission Electron Microscopy (TEM) images of MOF NPs.
Scale bars correspond to 100 nm.
Fig. 2 Chemical structure of furazan (A; top). Delivery proﬁle of fur-
azan from MIL-100(Fe) NPs in RPMI cell culture medium at 37 C (n ¼
3; mean  SD) (B; left). Furazan-engrafted MIL-100(Fe) MP stack at
diﬀerent depths (0.00, 0.74, 1.49 and 2.23 mm), showing homoge-
neous furazan engrafting observed by confocal microscopy (C; right).
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View Article Onlineand MIL-101_NH2 or the iron 2,5-dimethylterephthalates
MIL-88B_2CH3 and MIL-101_2CH3, was not diﬀerent (IC50 ¼
1.10 vs. 1.0 mg mL1 and 2.1 vs. 2.5 mg mL1, respectively),
indicating a poor eﬀect of the topology.
Eﬀect of the metal. On the whole, the toxicity depends on the
nature of the metal, with the Zn-based MOFs being more toxic
(ZIF-8: IC50 (HeLa) ¼ 0.100 mg mL1; (J774) ¼ 0.025 mg mL1)
followed by Zr-MOFs UiO-66 NPs (IC50 (J774) ¼ 0.06 mg mL1;
IC50 (HeLa) ¼ 0.40 mg mL1) and nally the less toxic Fe-based
MOF NPs (Table 1). Both Zn and Fe are related to important
biological functions,27 and are present in the body in relatively
signicant amounts (4 g).28 Although Zn is an endogenous266 | J. Mater. Chem. B, 2014, 2, 262–271element, it is well-known to induce considerable cellular
toxicity, as a consequence of its capacity to compete with Fe and
Ca ion channels, modifying their metabolism and therefore,
leading to cellular damage.29 Despite the high cytotoxicity
values disclosed by ZIF-8, these hybrid NPs exhibited IC50 values
comparable to those of other Zn oxide NPs.30 In addition,
Karlsson et al. evidenced an important cytotoxic eﬀect of ZnO
NPs in human lung epithelial A549 cell lines due to their
considerable ability to cause DNA damage.31 Recent toxicolog-
ical studies suggested that Zn toxicity is related to the rather
high solubility of Zn2+ ions.32 Here, we expect that ZIF-8 NPs are
progressively degraded into Zn2+ andmethyl-imidazolate (pKa
7.0 and 14.5) in cell culture media (pH  7.4 in the presence of
phosphates) as well as in an endosomal environment (pH 6.5–
4.5 and enzymes). Therewith, the high toxicity values of ZIF-8
could arise from the competition of Zn2+ with Fe2+ and Ca2+
cations through ion channels and/or DNA damage.
The Fe cytotoxicity, evidenced in J774 cells, was also
comparable to those of iron oxide NPs widely used as contrast
agents.33 However, Fe toxicity is generally related to diﬀerent
factors. First, it is well-known that Fen+ ions can generate
reactive oxygen species (ROS) through the Fenton or Harber–
Weiss reaction when in contact with cells.34 It is noteworthy that
redox active metals and ROS pathways alter the plasma
membrane potential, provoking changes in the gene expres-
sion35 and cell cycle regulation,36 nalising with cellular death
or apoptosis. Additionally, the formation of ROS could also be
the consequence of the membrane lipid peroxidation by NPs,
inducing cell damage.37 Finally, the intense Fe traﬃc in mito-
chondria, enabling the synthesis of heme and Fe–S clusters
involved in the cellular respiration, could be also aﬀected by an
iron overload.38 Therefore, the Fe sensibility of each cell type,
the same as their capability to avoid the trigger of these
mechanisms and their consequent cell damage, will dene
which cell type will be the most aﬀected. Despite the possibility
of Fen+ ions inducing toxicity, there are nowadays numerous
examples of iron oxide particles having very secure proles,
such as USPIO and SPIO with diﬀerent coatings (poly(ethylene
glycol) (PEG),39 caboxydextran,40 mannan41 dextran,42 etc.).
Although the impact of Zr4+ ions has not been studied as
wide as Fen+ or Zn2+, previous investigations reported several
coumarin Zr4+ complexes as antiproliferative agents.43 Their
IC50 values were of approximately 0.04 mg mL
1 for the highly
soluble Zr4+ salt (ZrCl4) in acute myeloid leukaemia derived
HL-60 and in chronic myeloid leukaemia LAMA-84 cells, a value
which was in total agreement with the important toxicity found
in J774 cells (IC50 ¼ 0.06 mg mL1).
Eﬀect of the organic linker. The inuence of the organic
constitutive linker has been mainly evaluated using iso-
structural Fe-based MOFs bearing various functionalised tere-
phthalate linkers (BDC_X; Table 1).
One shall keep here in mind that during their degradation
process at pH 7.4 and in the presence of phosphate groups, the
linkers might be progressively replaced by oxo or hydroxo
groups and/or phosphates and released into the media as
polycarboxylate anions (pKa  3–5). Degradation studies, per-
formed on DMEM medium + 10% FBS by elemental analysis,This journal is © The Royal Society of Chemistry 2014
Fig. 3 Representation of the IC50 values of MOF NPs in J774 cells vs.
the log P values of their constitutive ligands.
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View Article Onlineshowed however that except for the MIL-101_2CH3 and MIL-
88B_2CH3, the rest of the NPs did not exhibit a signicant
degradation aer 24 h, which could be related to a protective
eﬀect of the proteins adsorbed on the MOF outer surface. For
MIL-101_2CH3 and MIL-88B_2CH3 NPs, a partial degradation
was observed corresponding to 18.3  1.6 and 11.1  7.1%,
respectively.
Comparing the IC50 values in J774 cells, the values were in
agreement with the cytotoxicity for some ligands, supporting
that the cytotoxicity of MOF NPs was on the whole related to one
of their constitutive organic linkers. Nonetheless, this prole
was not followed for the BDC_CH3, BDC_2CH3 and BDC_NH2
MOF materials. Here again, this might be due to the internal-
isation of nanoparticles by endocytosis whereas linker mole-
cules could follow other cell penetration pathways.
Upon analysing the results in HeLa cells, it can be pointed
out that in general, linkers are “safe” considering their IC50
values above 1.00 mgmL1, except for BDC_NH2, Tazb and BDC
with nevertheless high IC50 values ranging between 0.60 and
0.80 mg mL1. However, this cytotoxicity prole cannot be
observed for the fumarate linker, as it is the most toxic one
(IC50 ¼ 0.03 mg mL1), comparable with our cytotoxicity value
using the J774 cells (IC50 ¼ 0.40 mg mL1), which clearly diﬀers
from our in vivo data.9b,15 MIL-88A NPs showed a low IC50,
comparable with currently other available nanoparticulate
systems.44 However, our cytotoxicity values here are unexpect-
edly high, when taking into account the endogenous character
of fumarate, and the absence of any in vivo toxicity for the
MIL-88A NPs.9b
Moreover, our previous in vivo toxicity studies evidenced the
lack of toxicity of MIL-88A, MIL-100 and MIL-88B_4CH3 NPs,
built from linkers exhibiting diﬀerent polarities. Aer the
intravenous administration of high doses of these MOFs, a fast
Fe removal and a dependent excretion rate of the ligands,
following their hydrophobic–hydrophilic character, were
observed.9b,15 Hydrophobic BDC_4CH3 was slowly removed, due
to its association with lipid droplets into macrophages
(liver and spleen), whereas the hydrophilic BTC linker was fast
excreted in urine due to its high polarity. Interestingly, hydro-
philic fumarate was not removed since this endogenous mole-
cule can be reused in the Krebs cycle.
In our study, the hydrophobic–hydrophilic balance (log P) of
the constitutive organic linker can be related to the MOF NP
cytotoxicity. Indeed, with the exception of MIL-88A NPs, a
roughly linear tendency between the partition coeﬃcients
(experimentally estimated log P) and cytotoxicity expressed in
IC50 values can be deduced (Fig. 3). However, this non-perfect
correlation means that the hydrophobic–hydrophilic balance is
not the only parameter ruling the cytotoxicity of MOF NPs.
The hydrophilic MIL-100(Fe) NPs showed an almost absence
of cytotoxicity with IC50 values of 0.70 mg mL
1 in J774 cells, in
agreement with our in vivo results. In contrast, MIL-88A and
MIL-88B_4CH3 showed almost 10 times lower IC50 values for the
same cell line, in agreement with our MIL-88A previous values.9b
Furthermore, even though these values correspond to a rela-
tively higher cytotoxicity when compared to other Fe-basedMOF
NPs, the absence of a signicant in vivo toxicity indicates thatThis journal is © The Royal Society of Chemistry 2014the in vitro toxicity does not necessarily involve a severe toxicity
in a complete organism, possessing specic clearance systems,
specialised on the removal of exogenous compounds.
Finally, the cytotoxicity values of polar functionalised MOF
NPs (MIL-101_NH2 and MIL-88B_NH2) on HeLa cells were
higher than those of the apolar dimethyl-functionalised MOF
NPs. Interestingly, the IC50 values obtained in HeLa cells were
dramatically higher (>1 mg mL1) than those corresponding to
J774 cells (<0.7 mg mL1). These diﬀerences could be explained
by the intrinsic properties of the two cell lines. First, the
unregulated cell growth characteristics of cancer cells45 might
lead to a higher resistance to external agents.46 Secondly, cyto-
toxicity might also be related to the cell internalisation capacity
of the particles, being higher in specialised cells, such as
macrophages.Cell penetration studies
In light of the cytotoxicity ndings, MIL-100(Fe) was chosen to
deepen cell penetration studies. This MOF was selected due to
its green synthesis, low toxicity prole and excellent perfor-
mance on drug encapsulation and release,9b being therefore a
good candidate as a future drug nanocarrier.
In order to investigate its cellular internalisation in J774
macrophages and epithelial HeLa cells, confocal microscopy
images of the cells treated with uorescent MIL-100(Fe) NPs
were taken at diﬀerent times. As seen in Fig. 4, the kinetics of
uptake was diﬀerent for the diﬀerent studied cell lines, being
faster in the case of J774 cells that showed a high uorescence at
early incubation times (30 min), than for HeLa cells, in which
uorescence appears more progressively. This variability of
uptake kinetics for the same particle has also been reported by
other authors and was attributed to their diﬀerent phagocytic
activities.47
Although there are no comparable results with MOFs in
cellular penetration, the cellular uptake of iron oxides such as
SPIONs in macrophages has been deeply studied. Hsiao et al.
analysed the morphological and physiological changes in
murine macrophages when adding Ferucarbotran (Resovist®)J. Mater. Chem. B, 2014, 2, 262–271 | 267
Fig. 4 Confocal microscopy images of HeLa (left) and J774 (right) cells containing furazan-engrafted MIL-100(Fe) NPs disassembled in furazan
(green; left), TOPRO (blue; centre) and merged (right) channels. The images were taken at diﬀerent times: 30 min, 1 h and 8 h. Moreover, 2
controls were made: cells and cells together with free furazan. The scale bar corresponds to 20 mm. All the images were taken at 63.
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View Article Onlineto cells, demonstrating particle accumulation in the membrane-
bound organelles.40b Also, the PEG coating of SPIONs provides
more positively charged surface particles, reducing the cellular
uptake. However, due to the antifouling properties of PEG,39
PEGylated SPIONs exhibit a lower cellular uptake by
macrophages.48
In our case, images taken at diﬀerent incubation times (t ¼
30 min, 1 h and 8 h) showed a rapid and easy internalisation of
the hybrid NPs inside J774 cells. Interestingly, uorescence was
detected in J774 cells immediately aer their contact with the
NPs, and remained during the 24 h of the study (not shown).
Also, no signicant diﬀerences in cell internalisation were
observed when comparing 30 min and 1 h of incubation with
the MOF, as also observed by Lunov et al. aer 30 min and 6 h of
incubation of macrophages with SPIONs.40a Besides, internal-
ised NPs were localised in cytoplasmatic organelles, such as
lysosomes, where they remained up to 24 h.40a Further268 | J. Mater. Chem. B, 2014, 2, 262–271investigations by the same group indicated that lysosomal
enzymes might degrade the dextran coating and the exposed
redox-active Fe3O4 would catalyse the generation of ROS, nal-
ising with cellular damage.
In contrast, aer 30 min and 1 h of incubation with the
MIL-100(Fe) NPs, almost no uorescence was observed in HeLa
cells. However, despite that HeLa cells are not specialised in
phagocytosis, an intense uorescence was observed aer 8 h of
incubation that lasted at least for 24 h (data not shown).
Moreover, the polarity of furazan was also an important
feature since this could modify its cell penetration as a free
moiety. Furazan showed a quite hydrophilic polar structure
meaning that cell permeation of this uorophore was reduced
in a lipophilic membrane. As observed in Fig. 4, both controls
showed no free uorophore inside, the entry of the uorophore
into the cells being possible only through encapsulation within
the pores of MIL-100(Fe). Also, although there is a furazanThis journal is © The Royal Society of Chemistry 2014
Fig. 5 Confocal images at diﬀerent depths in the Z-axis of HeLa cells (top) and J774 cells (bottom) after 8 h of incubation with furazan-loaded
MIL-100(Fe) NPs. The scale bars correspond to 20 mm. All the images are taken at 63.
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View Article Onlinerelease from MIL-100(Fe) NPs, the remaining amount aer 8 h
is still signicant enough for good localisation of the particles
and study of their cellular uptake, as shown in Fig. 2.This journal is © The Royal Society of Chemistry 2014To further determine whether these NPs were internalised
into the cells, confocal microscopy images were taken at
diﬀerent depths of the Z-axis. As can be seen in Fig. 5, aer 8 hJ. Mater. Chem. B, 2014, 2, 262–271 | 269
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View Article Onlineof incubation of the NPs with the cells, green uorescence was
observed at diﬀerent levels, corroborating that NPs were
internalised by the cells and not only externally adsorbed at the
cell membrane. Finally, it can be suggested that the higher
cytotoxicity of the NPs observed in J774 cells compared to that of
HeLa cells is probably related to (i) their faster internalisation in
J774 and therefore (ii) the larger residence time of the NPs
inside these cells and (iii) metabolic pathways that take place in
diﬀerent parts of the cell. It is important to consider that, if
exogenous materials remain for a longer time inside the cells,
the possibility to create cell damage increases. As NPs remain
longer in J774 than in HeLa cells, it is expected that the NPs will
be more toxic in J774 cells.Conclusions
A series of 14 MOFs were successfully synthesised at the nano-
scale and fully characterised, exhibiting a crystalline structure
and porosity comparable with their respective bulk materials.
The cytotoxicity of these MOF NPs was evaluated by the MTT
assay using two cell lines (J774 and HeLa), indicating low
toxicity values similar to those of other currently commercial-
ised nanometric systems. Indeed, cytotoxicity was observed to
strongly depend on the MOF composition such as: (i) the nature
of the metal, being less toxic for the Fe-based MOFs, compared
with the Zr- or Zn-MOF NPs and (ii) the constitutive organic
linker, the hydrophobic–hydrophilic balance being an impor-
tant parameter.
In addition, the higher cytotoxicity observed in J774 cells
compared to HeLa cells was mainly attributed to the faster
internalisation of NPs in the macrophage line. Moreover, the
stable uorophore graing within MIL-100(Fe) NPs allowed
evaluation of the cell uptake by confocal uorescence micros-
copy, indicating an immediate cell internalisation in J774
mouse macrophages, faster than in epithelial HeLa cell lines, in
agreement with their diﬀerent phagocytic activities.Acknowledgements
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